This activity is supported by an educational grant from Mylan.
On-demand CE Webinar
Clinical Strategies for Improving the Recognition and Treatment of Anaphylaxis
Laura L. Rooney, DNP, APRN, FNP-BC, DCC, BC-ADM, FAANP
Assistant Professor and Family Nurse Practitioner
UT Health School of Nursing
Anaphylaxis is a serious allergic reaction that requires prompt recognition and treatment. The median time to cardiac or respiratory arrest is 30 minutes for foods, 15 minutes for venom, and 5 minutes for medication-induced reactions. Although clinical guidelines are available, recent reports describe a rise in the incidence and prevalence of anaphylaxis. The immediate use of auto-injectable epinephrine (AIE) is preferred first-line treatment for anaphylaxis, however an Anaphylaxis in America survey reports, approximately 50% of patients with a prior allergic reaction had never received a prescription for AIE, and 60% of patients did not have AIE presently available. This webinar will review the treatment of anaphylaxis and discuss an anaphylaxis emergency action plan.
At the completion of this activity, the participant will be able to:
Identify clinical signs and symptoms consistent with a diagnosis of anaphylaxis
Explain the role of epinephrine in the treatment of anaphylaxis including pharmacodynamics, when to initiate use, proper dosing, and proper administration
Illustrate an anaphylaxis emergency action plan, including the important individual components, and review an example
March 23, 2017
March 23, 2018
Length of Webinar:
How to Obtain Credit
To receive credit, participants must complete the online pretest, view the activity in its entirety, and complete the online post-test and activity evaluation form. After completing the online assessment tests, and completing the activity evaluation form, participants may request credit. All participants must request credit before March 23, 2018. CE credit will not be issued after this date.
Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is accredited for 1.0 contact hour(s) which includes 0.0 hour(s) of pharmacology. Activity ID# 2199E.
This program was planned in accordance with AANP CE Standards and Policies
For information about the accreditation of this program, please contact Global at 303-395-1782 or firstname.lastname@example.org
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Laura L. Rooney, DNP, APRN, FNP-BC, DCC, BC-ADM, FAANP has the following relevant financial relationships with commercial interest to disclose:
The following contributors have no relevant financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™
Planning Staff: Dave Heckard, Maryjo Dixon, RPh, Donna Fausak, and Nicole Grassano.
Global Education Group Planners/Mangers:
Kristen Delisi, NP, Ashley Marostica, RN, MSN, and Andrea Funk.
Anonymous peer reviewers have been used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and ArcMesa do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Required: Windows 7, Vista, XP, 2003 Server or 2000
Required: Mac OS X 10.4.11 (Tiger) or newer
For questions about this Internet CPE activity, please contact: email@example.com